Clinical Research Directory
Browse clinical research sites, groups, and studies.
[18F]NIDF PET Imaging in Tau-related Diseases
Sponsor: Tianjin Medical University
Summary
In the field of diagnosing brain neurodegenerative diseases, it is now a well-established practice to inject positron-emitting tracers into the human body. These tracers bind to specific target proteins, allowing their distribution to be visualized via PET imaging. Currently, several research groups worldwide are engaged in developing and clinically validating their own tau imaging agents. This clinical research project aims to visualize abnormal tau pathology in the living human brain using \[18F\]NIDF PET imaging. \[18F\]NIDF is a 2-arene-azaindole-based tracer that offers stronger binding affinity to tau neurofibrillary tangles and reduced non-specific/off-target binding compared to existing tau-PET imaging agents. The study primarily focuses on evaluating the safety and diagnostic efficacy of \[18F\]NIDF PET imaging in human subjects.
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2025-11-01
Completion Date
2030-12-01
Last Updated
2025-12-29
Healthy Volunteers
Yes
Locations (2)
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, China
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China